Sponsored Links
Directory Sites
Advanced Vision Therapies, Inc.
Company focused on the treatment of sight-threatening eye diseases such as age-related macular degeneration and finding a cure.
www.avtxinc.com
Amsterdam Molecular Therapeutics
Focused on developing gene therapies for lipoprotein lipase disorder, inflammatory bowel disease and neuroregeneration. Also provides contract development and manufacturing of gene and cell-based products in their GMP facility.
www.amtbv.com
A gene medicine company developing a broad range of products based on vascular and endothelial molecular biology to treat vascular and circulatory diseases and cancer.
www.arktherapeutics.com
Gene delivery technology allowing pharmaceutical and genomics companies to assess the therapeutic value of identified genes and also allows genes to be used as therapeutic products to treat diseases from cancer to nervous and immune system disorders
www.biovex.com
Focused on the development and commercialization of cancer vaccines and gene therapies to treat various cancers including leukemia, hemophilia A and B, restenosis after angioplasty and Parkinson's disease.
www.cellgenesys.com
Pioneering genetic therapies for neurologic disorders.
www.ceregene.com
A product-driven cardiovascular gene therapy company, focused on the discovery, development and commercialization of novel and innovative non-surgical gene therapy products.
www.collateralthx.com
Developing human gene therapy products for cystic fibrosis and hemophilia B and DNA vaccinations. The company creates proprietary PLASmin Complexes which are efficient non-viral vectors and REPLIsome vectors which allow replication of non-viral vectors.
www.cgsys.com
Biotech company developing new therapies for the treatment of patients with severe cardiovascular and peripheral vascular disease using gene transfer approaches.
www.corautus.com
Bioventure company established at Nihon University School of Medicine. Focuses on the use of antisense nucleotides and ribozymes for the treatment of cardiovascular and renal diseases.
www.gentierinc.com
An emerging biopharmaceutical company developing novel gene therapies for diseases where local delivery of a therapeutic gene has potential benefits over currently available treatments. New product development initiatives have been formalized for coronary artery disease with BioBypass angiogen, restenosis prevention and cancer.
www.genvec.com
Focuses on developing gene transfer technologies for human gene therapy, gene-based immunotherapy, and gene-based drug discovery for cancer, AIDS, neurodegenerative and cardiovascular disease.
www.oxfordbiomedica.co.uk
Gene therapy company based in France is developing products for cancer and cystic fibrosis. Vector platforms include adenovirus, retrovirus, vaccinia virus, cellular and synthetic vectors.
www.transgene.fr
Developing gene-based therapeutics or "gene medicines" for the treatment of certain cancers, neuromuscular, cardiovascular, rheumatological and pulmonary diseases.
www.valentis.com
Company focusing on the development of therapeutic lentivirus vector technology for the delivery of short interfering RNA molecules.
www.vectorite.com